PL3368014T3 - Nowe preparaty kannabinoidów - Google Patents
Nowe preparaty kannabinoidówInfo
- Publication number
- PL3368014T3 PL3368014T3 PL16798004.4T PL16798004T PL3368014T3 PL 3368014 T3 PL3368014 T3 PL 3368014T3 PL 16798004 T PL16798004 T PL 16798004T PL 3368014 T3 PL3368014 T3 PL 3368014T3
- Authority
- PL
- Poland
- Prior art keywords
- new cannabinoid
- cannabinoid preparations
- preparations
- new
- cannabinoid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562246224P | 2015-10-26 | 2015-10-26 | |
| PCT/IL2016/051154 WO2017072762A1 (en) | 2015-10-26 | 2016-10-26 | Novel cannabinoid formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3368014T3 true PL3368014T3 (pl) | 2024-03-11 |
Family
ID=57345998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16798004.4T PL3368014T3 (pl) | 2015-10-26 | 2016-10-26 | Nowe preparaty kannabinoidów |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20180325861A1 (pl) |
| EP (2) | EP3368014B1 (pl) |
| AU (2) | AU2016347651A1 (pl) |
| DK (1) | DK3368014T3 (pl) |
| ES (1) | ES2968011T3 (pl) |
| PL (1) | PL3368014T3 (pl) |
| PT (1) | PT3368014T (pl) |
| WO (1) | WO2017072762A1 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2985332C (en) | 2015-05-18 | 2023-01-03 | 5071, Inc. | Homogenous cannabis compositions and methods of making the same |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| WO2019014631A1 (en) * | 2017-07-14 | 2019-01-17 | 5071, Inc. | Cannabinoid compositions and methods of preparation thereof |
| CA3079537A1 (en) * | 2017-09-02 | 2019-03-07 | Scientific Holdings, Llc | Tetrahydrocannabinol modulators |
| BR112020006841A2 (pt) * | 2017-10-05 | 2020-10-06 | Receptor Holdings, Inc. | formulações de canabinoide sintéticas e à base de planta com ação prolongada e início rápido |
| CA3108214A1 (en) | 2018-07-18 | 2020-01-23 | Glatt Gmbh | Extended release formulations of cannabinoids |
| BR112021001406A2 (pt) * | 2018-07-31 | 2021-04-27 | AusCann Group Holdings Ltd | composições farmacêuticas auto-emulsificantes sólidas |
| IL261132A (en) * | 2018-08-13 | 2018-11-04 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Formulated cannabis oil powder by nanoemulsifycation, methods of producing and uses thereof |
| AU2019326314A1 (en) * | 2018-08-20 | 2021-03-11 | Hexo Operations Inc. | Cannabis-infused product with controlled cannabinoid profile user experience |
| WO2020041326A1 (en) * | 2018-08-20 | 2020-02-27 | Berkowitz Barry A | Applications of known and novel cannabinoids |
| EP3873459A1 (en) | 2018-10-31 | 2021-09-08 | Enantia, S.L. | Solid compositions of cocrystals of cannabinoids |
| US20220008348A1 (en) * | 2018-11-08 | 2022-01-13 | Michael Golfetto | Compound delivery systems and methods of production |
| CA3119037A1 (en) * | 2018-12-11 | 2020-06-18 | Disruption Labs Inc. | Compositions for the delivery of therapeutic agents and methods of use and making thereof |
| US20200188298A1 (en) | 2018-12-14 | 2020-06-18 | NuVessl, Inc. | Method For Using Composition With Enhanced Passenger Molecule Loading |
| US20200215024A1 (en) * | 2019-01-08 | 2020-07-09 | Replennabis LLC | Cannabinoid formulations for treating alcohol hangover |
| WO2020234675A1 (en) * | 2019-04-30 | 2020-11-26 | Vialpando, Llc | Amorphous cannabinoid composition and processes of manufacture |
| US11596606B2 (en) | 2019-05-30 | 2023-03-07 | Metta Medical Inc | Activated cannabinoid controlled release compound tablet and method of forming the same |
| WO2021051105A2 (en) | 2019-09-12 | 2021-03-18 | Nulixir Inc. | Controlled release core-shell particles and suspensions including the same |
| JP2023504756A (ja) | 2019-12-09 | 2023-02-06 | ニコベンチャーズ トレーディング リミテッド | カンナビノイドを含む口腔用製品 |
| US20210251947A1 (en) * | 2020-02-10 | 2021-08-19 | TRYAGx Labs Inc. | Stable formulations of dronabinol |
| US20230210771A1 (en) * | 2020-06-10 | 2023-07-06 | Disruption Labs Inc. | Compositions for the delivery of therapeutic agents and methods of use and making thereof |
| EP4568702A1 (en) | 2022-08-12 | 2025-06-18 | Jazz Pharmaceuticals Research UK Limited | Oral solid dosage forms comprising cannabinoids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7919113B2 (en) | 1999-12-30 | 2011-04-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dispersible concentrate lipospheres for delivery of active agents |
| EP1559423A1 (en) * | 2004-02-02 | 2005-08-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Medicinal acidic cannabinoids |
| ES2581212T3 (es) | 2005-11-07 | 2016-09-02 | Murty Pharmaceuticals, Inc. | Administración mejorada de tetahidrocannabinol |
| US20140348926A1 (en) | 2012-01-19 | 2014-11-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Formulation and method for increasing oral bioavailability of drugs |
| CA3089686A1 (en) * | 2015-03-10 | 2016-09-15 | Nanosphere Health Sciences, Llc | A nanoparticle drug delivery comprising liquid lipids and cannabinoids encapsulated in a single layer of essential phospholipids |
-
2016
- 2016-10-26 AU AU2016347651A patent/AU2016347651A1/en not_active Abandoned
- 2016-10-26 PL PL16798004.4T patent/PL3368014T3/pl unknown
- 2016-10-26 US US15/770,905 patent/US20180325861A1/en not_active Abandoned
- 2016-10-26 WO PCT/IL2016/051154 patent/WO2017072762A1/en not_active Ceased
- 2016-10-26 DK DK16798004.4T patent/DK3368014T3/da active
- 2016-10-26 ES ES16798004T patent/ES2968011T3/es active Active
- 2016-10-26 PT PT167980044T patent/PT3368014T/pt unknown
- 2016-10-26 EP EP16798004.4A patent/EP3368014B1/en active Active
- 2016-10-26 EP EP23200565.2A patent/EP4279071A3/en active Pending
-
2022
- 2022-04-05 AU AU2022202259A patent/AU2022202259B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3368014A1 (en) | 2018-09-05 |
| WO2017072762A1 (en) | 2017-05-04 |
| EP3368014B1 (en) | 2023-10-04 |
| CA3003120A1 (en) | 2017-05-04 |
| US20180325861A1 (en) | 2018-11-15 |
| AU2022202259A1 (en) | 2022-04-21 |
| ES2968011T3 (es) | 2024-05-06 |
| AU2016347651A1 (en) | 2018-05-17 |
| EP4279071A3 (en) | 2024-01-17 |
| DK3368014T3 (da) | 2024-01-08 |
| PT3368014T (pt) | 2024-01-09 |
| EP4279071A2 (en) | 2023-11-22 |
| AU2022202259B2 (en) | 2023-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289084A (en) | Cannabinoid formulations | |
| IL252881A0 (en) | Microencapsulated cannabinoid compositions | |
| IL254516B (en) | Proteins specific for cd137 | |
| DK3283625T3 (da) | Nukleasemedieret genomeditering | |
| EP3286361A4 (en) | Cancer neoepitopes | |
| EP3119391C0 (en) | PROTEIN-BOUND CANNABINOID COMPOSITIONS | |
| DK3550859T3 (da) | Hovedtelefonsvirtualisering | |
| DK3331869T3 (da) | Muscarinagonister | |
| DK3331528T3 (da) | Muskarinagonister | |
| EP3331345A4 (en) | Hedge trimmer | |
| DK3277719T3 (da) | Polypeptider | |
| EP3316375A4 (en) | Redox flow cell | |
| DK3360890T3 (da) | Genterapi | |
| DK3305788T3 (da) | Janus-kinase-hæmmer | |
| EP3319983C0 (en) | TAU LINKING ANTIBODIES | |
| DK3331529T3 (da) | Muskarinagonister | |
| EP3290364A4 (en) | Conveyor belt wear monitoring system | |
| DK3310450T3 (da) | Olie-vand-separator | |
| IL261341B (en) | Branch instruction | |
| DK3394281T3 (da) | Gærcelle | |
| DK3270930T3 (da) | Præeklampsi | |
| EP3363322A4 (en) | Hair extender | |
| EP3325857A4 (en) | scraper | |
| DK3292136T3 (da) | Penicillin-g-acylaser | |
| DK3274482T3 (da) | Stenborsknop |